| MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy |
43 |
| Oxidative Stress and Cancer: The Role of Nrf2 |
34 |
| Oncorine, the World First Oncolytic Virus Medicine and its Update in China |
28 |
| Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer |
27 |
| Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects |
20 |
| Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation |
15 |
| Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update |
12 |
| Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR-Mutation Testing in NSCLC Patients: a Pooled Analysis |
9 |
| HSF1 as a Cancer Biomarker and Therapeutic Target |
8 |
| Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy |
8 |
| Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy |
7 |
| Recen Inhibi Updates on he Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer |
7 |
| Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis |
7 |
| Noxa Role in Cancer Pathogenesis and Treatment |
7 |
| Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives |
7 |
| Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer |
7 |
| Multimodal HDAC Inhibitors with Improved Anticancer Activity |
7 |
| Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers |
7 |
| Ponatinib: A Review of Efficacy and Safety |
7 |
| p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents |
7 |
| Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? |
7 |
| Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies |
6 |
| Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients |
6 |
| The Anti-malarial Drug Artesunate Blocks Wnt/beta-catenin Pathway an Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells |
6 |
| DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro cyclic 2-oxindole of Pyrimido[5-b]quinoline-6-dione Derivatives Against Breast Carcinoma |
6 |
| Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges |
5 |
| Anticancer Properties of Essenttal Oils: An Overview |
5 |
| Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome |
5 |
| A Comprehensive Review on Ethnomedicinal, Pharmacological and Phyto-chemical Basis of Anticancer Medicinal Plants of Pakistan |
5 |
| Tunneling Nanotubes: A Versatile Target for Cancer Therapy |
5 |
| Towards Prevention of Ovarian Cancer |
5 |
| Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling |
5 |
| Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System |
5 |
| Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents |
5 |
| An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein |
5 |
| Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications |
4 |
| The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma |
4 |
| c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression |
4 |
| Development of Drug Targeting and Delivery in Cervical Cancer |
4 |
| Epigenetics in Metastatic Breast Cancer Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics |
4 |
| Current and Emerging Treatments for Metastatic Renal Cell Carcinoma |
4 |
| Obesity and Cancer: Biological Links and Treatment Implications |
4 |
| The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy |
4 |
| Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs/PEI/miRNA/HA Nanocomplexes |
3 |
| Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced-penetration Paclitaxel Nanosuspension |
3 |
| Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics |
3 |
| Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells |
3 |
| Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors |
3 |
| Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway |
3 |
| JQ a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells |
3 |
